Resapp Health Ltd
ASX:RAP
Resapp Health Ltd
ASX:RAP
Price:
0.205 AUD
Market Closed
Updated:
May 7, 2024
Resapp Health Ltd
Research & Development
|
Resapp Health Ltd
Research & Development Peer Comparison
Comparables:
M7T
4DX
CGS
PME
MDR
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Resapp Health Ltd
ASX:RAP
|
Research & Development
-AU$5.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-37%
|
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Research & Development
-AU$4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medadvisor Ltd
ASX:MDR
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Resapp Health Ltd's Research & Development?
Research & Development
-5.8m
AUD
-5.8m
AUD
Based on the financial report for Jun 30, 2022, Resapp Health Ltd's Research & Development amounts to -5.8m AUD.
What is Resapp Health Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-37%
-37%
Over the last year, the Research & Development growth was -36%. The average annual Research & Development growth rates for Resapp Health Ltd have been 3% over the past three years , -11% over the past five years , and -37% over the past ten years .
You don't have any saved screeners yet
